» Articles » PMID: 29499275

Altered Hippocampal Synaptic Function in Transgenic Mice with Increased Astrocyte Expression of CCL2 After Withdrawal from Chronic Alcohol

Overview
Specialties Neurology
Pharmacology
Date 2018 Mar 3
PMID 29499275
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

CNS actions of the chemokine CCL2 are thought to play a role in a variety of conditions that can have detrimental consequences to CNS function, including alcohol use disorders. We used transgenic mice that express elevated levels of CCL2 in the CNS (CCL2-tg) and their non-transgenic (non-tg) littermate control mice to investigate long-term consequences of CCL2/alcohol/withdrawal interactions on hippocampal synaptic function, including excitatory synaptic transmission, somatic excitability, and synaptic plasticity. Two alcohol exposure paradigms were tested, a two-bottle choice alcohol (ethanol) drinking protocol (2BC drinking) and a chronic intermittent alcohol (ethanol) (CIE/2BC) protocol. Electrophysiological measurements of hippocampal function were made ex vivo, starting ∼0.6 months after termination of alcohol exposure. Both alcohol exposure/withdrawal paradigms resulted in CCL2-dependent interactions that altered the effects of alcohol on synaptic function. The synaptic alterations differed for the two alcohol exposure paradigms. The 2BC drinking/withdrawal treatment had no apparent long-term consequences on synaptic responses and long-term potentiation (LTP) in hippocampal slices from non-tg mice, whereas synaptic transmission was reduced but LTP was enhanced in hippocampal slices from CCL2-tg mice. In contrast, the CIE/2BC/withdrawal treatment enhanced synaptic transmission but reduced LTP in the non-tg hippocampus, whereas there were no apparent long-term consequences to synaptic transmission and LTP in hippocampus from CCL2-tg mice, although somatic excitability was enhanced. These results support the idea that alcohol-induced CCL2 production can modulate the effects of alcohol exposure/withdrawal on synaptic function and indicate that CCL2/alcohol interactions can vary depending on the alcohol exposure/withdrawal protocol used.

Citing Articles

Astrocytes modulate cerebral blood flow and neuronal response to cocaine in prefrontal cortex.

Du C, Park K, Hua Y, Liu Y, Volkow N, Pan Y Mol Psychiatry. 2024; 29(3):820-834.

PMID: 38238549 PMC: 11784220. DOI: 10.1038/s41380-023-02373-9.


Neuroimmune interactions with binge alcohol drinking in the cerebellum of IL-6 transgenic mice.

Gruol D, Calderon D, French K, Melkonian C, Huitron-Resendiz S, Cates-Gatto C Neuropharmacology. 2023; 228:109455.

PMID: 36775097 PMC: 10029700. DOI: 10.1016/j.neuropharm.2023.109455.


Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement.

Steel T, Afshar M, Edwards S, Jolley S, Timko C, Clark B Am J Respir Crit Care Med. 2021; 204(7):e61-e87.

PMID: 34609257 PMC: 8528516. DOI: 10.1164/rccm.202108-1845ST.


CCL2/CCR2 Chemokine System in Embryonic Hypothalamus: Involvement in Sexually Dimorphic Stimulatory Effects of Prenatal Ethanol Exposure on Peptide-Expressing Neurons.

Chang G, Karatayev O, Boorgu D, Leibowitz S Neuroscience. 2019; 424:155-171.

PMID: 31705896 PMC: 6943193. DOI: 10.1016/j.neuroscience.2019.10.013.


Neuroimmune signaling in alcohol use disorder.

Erickson E, Grantham E, Warden A, Harris R Pharmacol Biochem Behav. 2018; 177:34-60.

PMID: 30590091 PMC: 6946054. DOI: 10.1016/j.pbb.2018.12.007.

References
1.
Kyzar E, Pandey S . Molecular mechanisms of synaptic remodeling in alcoholism. Neurosci Lett. 2015; 601:11-9. PMC: 4506731. DOI: 10.1016/j.neulet.2015.01.051. View

2.
Christian D, Alexander N, Diaz M, Robinson S, McCool B . Chronic intermittent ethanol and withdrawal differentially modulate basolateral amygdala AMPA-type glutamate receptor function and trafficking. Neuropharmacology. 2012; 62(7):2430-9. PMC: 3314101. DOI: 10.1016/j.neuropharm.2012.02.017. View

3.
Little H . The contribution of electrophysiology to knowledge of the acute and chronic effects of ethanol. Pharmacol Ther. 2000; 84(3):333-53. DOI: 10.1016/s0163-7258(99)00040-6. View

4.
Zhou Y, Tang H, Liu J, Dong J, Xiong H . Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem. 2010; 116(3):406-14. PMC: 3018532. DOI: 10.1111/j.1471-4159.2010.07121.x. View

5.
Guyon A, Skrzydelski D, De Giry I, Rovere C, Conductier G, Trocello J . Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience. 2009; 162(4):1072-80. DOI: 10.1016/j.neuroscience.2009.05.048. View